Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
CRA: Stock Quote & Summary Data
0.79%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | $ 8.00 |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 769,745 |
| Previous Close | $ 6.30 |
| 52 Wk High / Low | $ 11.71 / $ 5.03 |
| Shares Outstanding | 81,818,000 |
| Market Value | $ 511,362,500 |
| P/E Ratio | NE |
| Forward P/E (1yr) | 210.00 |
| Earnings Per Share | $ -0.19 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 0.73 |
| NASDAQ Official Open Price: | $ 6.27 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 6.25 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About CRA?
Ask your question about about Celera Corporation (CRA) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
History Prior to July 1, 2008, we operated as a reporting unit of Applied Biosystems, Inc. (Applied Biosystems), formerly known as Applera Corporation (Applera), and not as a stand-alone company. Applied Biosystems established the following two classes of common stock, sometimes referred to as tracking stocks, which were intended to reflect separately the relative performance of Applied Biosystems’ two businesses: • Applied Biosystems Group common stock that was intended to reflect the relative performance of the Applied Biosystems Group; and • Celera Group common stock that was intended to reflect the relative performance of the Celera Group. ... More ...
Links to all Celera Corporation (CRA) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for CRA |
||
|
9 Things You Should Do Instead of Buying Stocks - The Motley Fool 11/18/2009 2:17PM |
||
|
Celera Licenses Lung Cancer Intellectual Property from Medical Therapies - Business Wire 10/29/2009 4:30PM |
||
|
Celera Q3 Loss Widens; Provides Guidance - Quick Facts - RTT News 10/28/2009 5:44PM |
||
|
Berkeley HeartLab Enters into Agreements with Proven Diagnostics and Geisinger Medical Center to Provide Testing for Cardiovascular Disease - Business Wire 10/28/2009 4:02PM |
||
|
Celera Corporation Reports Third Quarter 2009 Results - Business Wire 10/28/2009 4:01PM |
||
|
Celera Q3 09 Earnings Conference Call At 4:30 PM - RTT News 10/28/2009 1:51PM |
||
|
Celera Corporation Third Quarter Fiscal 2009 Results and Conference Call Scheduled for October 28, 2009 - Business Wire 10/21/2009 5:11PM |
Consensus Recommendation |
|
Analyst Info |
|
| Annual EPS Est: | $ -0.26 |
| Quarterly EPS Est: | $ -0.03 |
| PEG Ratio: | 72.00 |
| Mean Recommendation: View Summary/View All |
2.43 |
